JP2009269923A5 - - Google Patents

Download PDF

Info

Publication number
JP2009269923A5
JP2009269923A5 JP2009185305A JP2009185305A JP2009269923A5 JP 2009269923 A5 JP2009269923 A5 JP 2009269923A5 JP 2009185305 A JP2009185305 A JP 2009185305A JP 2009185305 A JP2009185305 A JP 2009185305A JP 2009269923 A5 JP2009269923 A5 JP 2009269923A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
formulation
unit dose
less
tobramycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009185305A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009269923A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2009269923A publication Critical patent/JP2009269923A/ja
Publication of JP2009269923A5 publication Critical patent/JP2009269923A5/ja
Pending legal-status Critical Current

Links

JP2009185305A 2001-05-18 2009-08-07 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物 Pending JP2009269923A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29223401P 2001-05-18 2001-05-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002590936A Division JP2004534763A (ja) 2001-05-18 2002-05-17 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物

Publications (2)

Publication Number Publication Date
JP2009269923A JP2009269923A (ja) 2009-11-19
JP2009269923A5 true JP2009269923A5 (enExample) 2010-09-02

Family

ID=23123791

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002590936A Pending JP2004534763A (ja) 2001-05-18 2002-05-17 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物
JP2009185305A Pending JP2009269923A (ja) 2001-05-18 2009-08-07 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002590936A Pending JP2004534763A (ja) 2001-05-18 2002-05-17 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物

Country Status (11)

Country Link
US (8) US20030143162A1 (enExample)
EP (2) EP2186508A3 (enExample)
JP (2) JP2004534763A (enExample)
AT (1) ATE322249T1 (enExample)
AU (1) AU2010210026A1 (enExample)
CA (1) CA2447600C (enExample)
DE (1) DE60210402T2 (enExample)
DK (1) DK1320355T3 (enExample)
ES (1) ES2261735T3 (enExample)
PT (1) PT1320355E (enExample)
WO (1) WO2002094217A1 (enExample)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
CA2447600C (en) * 2001-05-18 2015-10-20 Chiron Corporation Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
US20040022740A1 (en) * 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
US20030059375A1 (en) * 2001-08-20 2003-03-27 Transave, Inc. Method for treating lung cancers
EP1458360B1 (en) * 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
US7607436B2 (en) * 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US7334580B2 (en) * 2002-05-07 2008-02-26 Smaldone Gerald C Methods, devices and formulations for targeted endobronchial therapy
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
CN1681478A (zh) * 2002-08-02 2005-10-12 川塞夫有限公司 铂聚集体及其制备方法
AU2002953095A0 (en) * 2002-11-29 2002-12-19 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
US20070071686A1 (en) * 2003-10-15 2007-03-29 Pari Gmbh Liquid preparation containing tobramycin
US20070065522A1 (en) * 2004-03-18 2007-03-22 Transave, Inc. Administration of high potency platinum compound formulations by inhalation
EP1729786A4 (en) * 2004-03-18 2008-03-26 Transave Inc ADMINISTRATION OF CISPLATIN BY INHALATION
ES2358024T3 (es) 2004-05-17 2011-05-04 Gilead Sciences, Inc. Combinación de fosfomicina/aminoglucósido aerosolizada para el tratamiento de las infecciones respiratorias bacterianas.
US20060034906A1 (en) * 2004-05-21 2006-02-16 Transave, Inc. Treatment of lung diseases and pre-lung disease conditions
CA2570976C (en) 2004-06-18 2013-08-13 Novartis Vaccines And Diagnostics, Inc. Methods of treatment of endobronchial infections
KR20070089693A (ko) * 2004-11-08 2007-08-31 트랜세이브, 인코포레이티드 지질-기재 플래티넘 화합물 제형을 복막내 투여하여 암을치료하는 방법
CA2622193A1 (en) * 2005-09-29 2007-04-12 Nektar Therapeutics Antibiotic formulations, unit doses, kits, and methods
AU2013206401B2 (en) * 2005-09-29 2016-06-23 Novartis Ag Antibiotic formulations, unit doses, kits, and methods
US20070190182A1 (en) * 2005-11-08 2007-08-16 Pilkiewicz Frank G Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
US20070190181A1 (en) * 2005-11-08 2007-08-16 Pilkiewicz Frank G Methods of treating cancer with lipid-based platinum compound forumulations administered intravenously
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
US20070190180A1 (en) * 2005-11-08 2007-08-16 Pilkiewicz Frank G Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
US20070122350A1 (en) * 2005-11-30 2007-05-31 Transave, Inc. Safe and effective methods of administering therapeutic agents
CA2896083A1 (en) 2005-12-08 2007-06-14 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
US8337814B2 (en) * 2005-12-15 2012-12-25 Topical Sinus Therapeutics, Inc. Treatment of active infections, sinusitis, rhinitis, and related neurological disorders and related compositions
JP2008199905A (ja) * 2007-02-16 2008-09-04 Snow Brand Milk Prod Co Ltd 乳酸菌生残性向上剤
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
US20110049634A1 (en) * 2008-04-02 2011-03-03 Nxp B.V. Method of manufacturing a semiconductor device and semiconductor device
CN102245195B (zh) * 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
EP3009442B1 (en) 2010-03-22 2019-06-19 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
CA2799937A1 (en) 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
BR112013000921A2 (pt) * 2010-07-12 2016-05-17 Xellia Pharmaceuticals Aps tratamento de infecções pulmonares pela administração de tobramicina por aerolização
WO2012034058A1 (en) 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
JP2014523909A (ja) 2011-07-12 2014-09-18 カーディアス ファーマ コーポレイション 人工呼吸器関連肺炎（ｖａｐ）及び人工呼吸器関連気管（ｖａｔ）気管支炎の治療のためのアミカシンとホスホマイシンの組み合わせの製剤並びに方法及びシステム
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
GB201208080D0 (en) 2012-05-09 2012-06-20 Norton Healthcare Ltd Tobramycin formulation
DK2892524T3 (da) 2012-09-04 2021-01-25 Eleison Pharmaceuticals LLC Forebyggelse af pulmonalt kræfttilbagefald med lipid-komplekseret cisplatin
WO2014085526A1 (en) 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
JP6316846B2 (ja) 2013-01-11 2018-04-25 クセリア ファーマシューティカルズ エーピーエスＸｅｌｌｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ ポリミキシン含有組成物
HK1217665A1 (zh) * 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
HK1218864A1 (zh) 2013-03-15 2017-03-17 森普拉制药公司 用於制备大环内酯抗菌剂的收敛方法
KR102447412B1 (ko) 2014-05-15 2022-09-23 인스메드 인코포레이티드 폐의 비-결핵성 마이코박테리아 감염을 치료하기 위한 방법
EP3166960B1 (en) 2014-07-09 2019-08-07 Xellia Pharmaceuticals ApS Low substituted polymyxins and compositions thereof
HUE052028T2 (hu) 2014-10-03 2021-04-28 Xellia Pharmaceuticals Aps Kompozíciók
ES2721401T3 (es) 2014-10-03 2019-07-31 Xellia Pharmaceuticals Aps Dispositivo de inhalación
US10617703B2 (en) 2014-12-10 2020-04-14 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11690815B2 (en) 2015-08-05 2023-07-04 Cmpd Licensing Llc Hyperkeratotic skin condition treatments and compositions
US10898455B2 (en) 2016-01-07 2021-01-26 Cmpd Licensing, Llc Urea cream formulations
US11278590B2 (en) 2015-08-05 2022-03-22 Cmpd Licensing, Llc Compositions and methods for treating nail infections
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10898491B2 (en) 2015-12-18 2021-01-26 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US9999604B2 (en) 2016-11-17 2018-06-19 Cmpd Licensing, Llc Compounded solutions of diclofenac and lidocaine and methods
US10525025B2 (en) 2016-11-17 2020-01-07 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
JP7460534B2 (ja) 2018-03-30 2024-04-02 インスメッド インコーポレイテッド リポソーム医薬品の連続製造方法
WO2020163416A1 (en) * 2019-02-05 2020-08-13 Mylan Inc Devices and methods for tobramycin inhalation treatment

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993223A (en) 1974-07-25 1976-11-23 American Home Products Corporation Dispensing container
US4502616A (en) 1982-01-04 1985-03-05 Health Care Concepts, Inc. Single use vial
GB8801655D0 (en) 1988-01-26 1988-02-24 Waverley Pharma Ltd Ampoules
ES2038445T3 (es) 1988-01-28 1993-07-16 Lameplast S.R.L. Tiras de ampollas para productos farmaceuticos, cosmeticos y otros.
GB8802349D0 (en) 1988-02-03 1988-03-02 Waverley Pharma Ltd Ampoule with luer
DE3916840A1 (de) 1988-09-21 1990-03-29 Bernd Hansen Ampulle
US5409125A (en) 1989-12-11 1995-04-25 Aktiebolaget Astra Unit dose container
CA2027690A1 (en) 1990-10-18 1992-04-19 Christian Laing Plastic ampul
FR2687066A1 (fr) 1992-02-06 1993-08-13 Oreal Ampoule autocassable.
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5758637A (en) * 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US6083922A (en) * 1996-04-02 2000-07-04 Pathogenesis, Corp. Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
CZ20012147A3 (cs) * 1998-12-17 2003-01-15 Chiron Corporation Farmaceutický prostředek ve formě suchého práąku nebo rozpráąeného aerosolového prostředku pro léčení chronické bronchitidy
SE9902627D0 (sv) * 1999-07-08 1999-07-08 Siemens Elema Ab Medical nebulizer
DE19953317C1 (de) 1999-11-05 2001-02-01 Pari Gmbh Inhalationsvernebler
CA2447600C (en) 2001-05-18 2015-10-20 Chiron Corporation Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics

Similar Documents

Publication Publication Date Title
JP2009269923A5 (enExample)
US10835512B2 (en) Methods of treating respiratory syncytial virus infections
JP2011520911A5 (enExample)
JP6429788B6 (ja) 化合物送達のためのデバイス
US20220304980A1 (en) Metered dosing compositions and methods of use of psychedelic compounds
JP5863641B2 (ja) 濃縮肥満細胞安定化用薬学的調合物
JP2010526837A5 (enExample)
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
MX2009009131A (es) Mejoras en y con relacion a composiciones medicinales.
JP2008044951A5 (enExample)
Cazzola et al. Inhaled medication: which device for which patient
JP2006508994A5 (enExample)
JP2013522295A5 (enExample)
JP6945614B2 (ja) 経鼻投与
JP2006508993A5 (enExample)
Keller et al. In-vivo data support equivalent therapeutic efficacy of a new tobramycin inhalation solution (150 mg/1.5 mL) administered by the eFlow® electronic nebuliser compared to TOBI® in the PARI LC PLUS®
RU75944U1 (ru) Аэрозольная форма лекарственного средства
Geller et al. Treatment convenience and satisfaction of tobramycin inhalation powder (TIP) versus TOBI in cystic fibrosis (CF) patients
Konstan et al. Safety and efficacy of tobramycin inhalation powder (TIP) in treating CF patients infected with Pseudomonas aeruginosa (Pa)
Wainwright et al. 81* A double-blind, multinational, randomized, placebo-controlled trial evaluating aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis (CF), mild lung disease and P. aeruginosa (PA)
CN201036611Y (zh) 一种心脏急救药盒
CN104582690A (zh) 用于经鼻部施用的组合物
EA201590323A1 (ru) Способ введения активных веществ в головной мозг
RU2015147233A (ru) Способы лечения, включающие эсликарбазепин или эсликарбазепина ацетат
CN102526101A (zh) 一种治疗牙疼的药物